Asensus Surgical, Inc. (ASXC)
NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.243
-0.006 (-2.41%)
At close: Apr 24, 2024, 4:00 PM
0.255
+0.012 (4.94%)
Pre-market: Apr 25, 2024, 7:11 AM EDT

Asensus Surgical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Revenue
8.587.098.233.188.5324.17.111.5200.4
Upgrade
Revenue Growth (YoY)
21.02%-13.91%159.28%-62.78%-64.60%238.94%368.14%---71.98%
Upgrade
Cost of Revenue
13.1610.8711.15.1720.7316.176.731.0701.1
Upgrade
Gross Profit
-4.58-3.79-2.86-1.99-12.27.930.380.450-0.69
Upgrade
Selling, General & Admin
36.0834.9332.7227.246.7739.5929.8119.9610.697.47
Upgrade
Research & Development
37.0228.9419.3516.6222.4721.8221.9929.2729.6727.94
Upgrade
Other Operating Expenses
0.839.1411.2511.6582.69-3.327.8674.386.420.5
Upgrade
Operating Expenses
73.9373.0163.3255.47151.9358.0959.66123.6246.7735.92
Upgrade
Operating Income
-78.5-76.79-66.18-57.47-164.13-50.16-59.27-123.17-46.77-36.61
Upgrade
Interest Expense / Income
00.410.370.023.614.212.442.021.61.04
Upgrade
Other Expense / Income
-0.39-1.96-4.323.34-10.4110.7886.380.32-0.4-
Upgrade
Pretax Income
-78.12-75.24-62.24-60.83-157.33-65.15-148.1-125.5-47.97-37.65
Upgrade
Income Tax
0.310.320.23-1.52-3.12-3.38-3.3-5.52-1.020
Upgrade
Net Income
-78.43-75.56-62.46-59.31-154.2-61.78-144.8-119.98-46.95-37.65
Upgrade
Preferred Dividends
0000.71000000
Upgrade
Net Income Common
-78.43-75.56-62.46-60.02-154.2-61.78-144.8-119.98-46.95-37.65
Upgrade
Shares Outstanding (Basic)
25023622771181611965
Upgrade
Shares Outstanding (Diluted)
25023622771181611965
Upgrade
Shares Change
5.58%4.20%220.52%299.22%11.29%39.30%32.59%40.89%35.62%361.19%
Upgrade
EPS (Basic)
-0.31-0.32-0.28-0.85-8.69-3.88-12.61-13.91-7.67-8.32
Upgrade
EPS (Diluted)
-0.31-0.32-0.28-0.85-8.69-3.88-12.61-13.91-7.67-8.32
Upgrade
Free Cash Flow
-64.19-60.22-42.03-46.68-57.96-49.23-49.29-53.75-39.99-35.5
Upgrade
Free Cash Flow Per Share
-0.26-0.26-0.18-0.66-3.27-3.09-4.31-6.23-6.53-7.86
Upgrade
Gross Margin
-53.38%-53.41%-34.79%-62.71%-143.01%32.91%5.40%29.62%--173.07%
Upgrade
Operating Margin
-915.29%-1083.59%-803.98%-1809.92%-1923.90%-208.13%-833.55%-8108.43%--9129.43%
Upgrade
Profit Margin
-914.46%-1066.19%-758.77%-1890.49%-1807.54%-256.31%-2036.23%-7898.62%--9389.53%
Upgrade
Free Cash Flow Margin
-748.37%-849.67%-510.53%-1470.17%-679.36%-204.26%-693.10%-3538.31%--8853.37%
Upgrade
EBITDA
-74.39-63.76-47.76-47.11-141.25-47.66-135.31-114.57-42.94-35.3
Upgrade
EBITDA Margin
-867.32%-899.63%-580.13%-1483.78%-1655.74%-197.73%-1902.81%-7542.66%--8802.74%
Upgrade
Depreciation & Amortization
3.7311.0814.1113.712.4713.2910.348.913.431.31
Upgrade
EBIT
-78.12-74.83-61.87-60.81-153.72-60.95-145.65-123.48-46.37-36.61
Upgrade
EBIT Margin
-910.80%-1055.92%-751.54%-1915.24%-1801.88%-252.87%-2048.28%-8129.16%--9129.43%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).